Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
16,033,728
-
Share change
-
+1,935,604
-
Total reported value
-
$47,380,324
-
Put/Call ratio
-
8.7%
-
Price per share
-
$2.96
-
Number of holders
-
31
-
Value change
-
+$6,283,557
-
Number of buys
-
13
-
Number of sells
-
10
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q2 2023
As of 30 Jun 2023 AC Immune SA - SHS (ACIU) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,033,728 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Avidity Partners Management LP, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Eversept Partners, LP, Assenagon Asset Management S.A., and Handelsbanken Fonder AB.
This table shows 31 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.